Sat Kartar Life Share Price Today | Stock Price & Sat Kartar Life Share Screener
Track the current Sat Kartar Life share price and stock price live with TickJournal's free stock screener. Check SATKARTAR 52-week high low for the annual price range and momentum. Use the Sat Kartar Life stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sat Kartar Life opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Sat Kartar Life Share Price Chart
Track the current stock price of Sat Kartar Life with an interactive chart. Analyse SATKARTAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sat Kartar Life stock quote in one place.
Sat Kartar Life Company Profile - Fundamental Screener
Screen Sat Kartar Life company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SATKARTAR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0NB801022.
Company Details
Classification
Identifiers and Leadership
Sat Kartar Life Balance Sheet Screener
Screen SATKARTAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹85, up from ₹65 in 2025.
Latest statistics put total assets at ₹85 and shareholder funds at ₹68, with a leverage ratio of 0.07.
| Item | 2026 | 2025 |
|---|---|---|
Assets |
||
| Total Assets | 85 | 65 |
| Current Assets | 69 | 56 |
| Fixed Assets | 11 | 6 |
Liabilities |
||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 2 | 2 |
| Non-Current Liabilities | 0 | 0 |
Shareholders' Equity |
||
| Total Equity | 68 | 52 |
| Share Capital | 16 | 16 |
| Reserves & Surplus | 52 | 36 |
Sat Kartar Life Income Statement Screener - Profit & Revenue Analysis
Screen Sat Kartar Life income statement and profit fundamentals. Analyze SATKARTAR quarterly results. Sat Kartar Life reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹203 and net profit of ₹17.
| Item | None-None | 2026-March | 2025-March |
|---|---|---|---|
Revenue and Expenses | |||
| Revenue | 0 | 203 | 164 |
| Expenses | 0 | 176 | 149 |
Operating Costs and Margins | |||
| EBITDA | 0 | 27 | 15 |
| Operating Profit % | 0.00% | 12.00% | 9.00% |
| Depreciation | 0 | 3 | 1 |
| Interest | 0 | 1 | 1 |
Profit and Earnings | |||
| Profit Before Tax | 0 | 23 | 13 |
| Tax | 0 | 6 | 3 |
| Net Profit | 0 | 17 | 10 |
| EPS | 0.00 | 10.86 | 7.37 |
Sat Kartar Life Cash Flow Screener - Liquidity Fundamentals
Screen SATKARTAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹1, and net cash flow was an outflow of ₹9.
Over the same period, investing activities used ₹9 and financing activities used ₹1.
| Item | 2026-March | 2025-March |
|---|---|---|
Cash from Operations and Investing | ||
| Operating Activities | 1 | -5 |
| Investing Activities | -9 | 0 |
Financing and Net Cash | ||
| Financing Activities | -1 | 34 |
| Net Cash Flow | -9 | 28 |
Sat Kartar Life Shareholding Pattern Screener
See Sat Kartar Life shareholding pattern with promoter, FII, and DII holdings. Check Sat Kartar Life promoter holding and ownership changes for SATKARTAR on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 63.62%, foreign institutions 0.13%, domestic institutions 2.26% and the public 27.29%, spread across 846 shareholders.
The shareholder count was 846 in 2026-Mar, compared with 1,311 in 2025-Jan.
| Item | 2026-Mar | 2025-Jan | 2025-Mar | 2025-Sept | 2024-Jul |
|---|---|---|---|---|---|
Promoter Holding | |||||
| Promoter Holding | 63.62% | 63.31% | 63.34% | 63.43% | 85.72% |
Institutional Investors | |||||
| FII Holding | 0.13% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.26% | 1.89% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | |||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.29% | 19.23% | 17.81% | 24.41% | 13.45% |
| Other Holding | 6.71% | 15.57% | 18.85% | 12.16% | 0.83% |
| Shareholder Count | 846 | 1,311 | 425 | 717 | 28 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sat Kartar Life. Sat Kartar Life dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.70 per unit for 2026-March, a yield of 0.39%, compared with ₹0.70 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.70, ₹0.70 and ₹0.70 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.70 | 0.39% |
| 2025-March | ₹0.70 | 0.47% |
| 2024-March | ₹0.70 | 0.46% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sat Kartar Life Stock Index Membership - Nifty & Sensex
See which indices include Sat Kartar Life stock. Check SATKARTAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Sat Kartar Life Market Events Screener - Corporate Actions
Get Sat Kartar Life corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sat Kartar Life stock events that may affect SATKARTAR share price, along with derivatives, futures and options activity and sector gainers.
7 corporate actions are listed, the most recent entry being Dividend dated August 21, 2026, with a record date of August 21, 2026.
It is followed by Extraordinary General Meeting dated May 13, 2026 and Quarterly Result Announcement dated May 5, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-21 | 2026-08-21 | Dividend | ₹ 0.70 /share | -10.34% |
| 2026-05-13 | 2026-05-13 | Extraordinary General Meeting | NA | 3.73% |
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | -1.63% |
| 2026-01-05 | 2026-01-05 | Change Of Name | NA | 0.00% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | 5.20% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 0.70 /share | -1.81% |
| 2025-05-17 | 2025-05-17 | Quarterly Result Announcement | NA | 13.56% |
Sat Kartar Life Competitors Screener - Peer Stocks Comparison
Screen SATKARTAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 435,863 | 36.83 | 61,674 | 12.69% | 11,565 | 38.95 |
| Divis Laboratories | 246,660 | 86.00 | 11,067 | 13.95% | 2,568 | 53.27 |
| Torrent Pharmaceuticals | 182,577 | 86.72 | 13,886 | 20.34% | 2,138 | 42.82 |
| Zydus Life Science | 115,910 | 25.96 | 27,658 | 17.64% | 5,026 | 51.33 |
| Cipla | 108,738 | 33.29 | 29,045 | 2.24% | 3,870 | 35.23 |
| Laurus Labs | 106,982 | 98.39 | 6,868 | 22.01% | 890 | 58.13 |
| Mankind Pharma | 103,418 | 50.84 | 14,636 | 14.85% | 1,938 | 59.40 |
| Dr Reddys Laboratories | 102,916 | 32.77 | 35,059 | 3.90% | 4,158 | 62.37 |
| Aurobindo Pharma | 96,203 | 26.41 | 34,145 | 5.56% | 3,503 | 49.32 |
| Lupin | 92,839 | 16.97 | 29,039 | 26.75% | 5,356 | 31.32 |
Sat Kartar Life Company Announcements - News & Reports Screener
Screen SATKARTAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 4.14. Market capitalisation stands at ₹306.59 Cr and the dividend yield is 0.39%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.